View source for Document:INT ISPE - GPP Revision 3 (2015)

<noinclude>{{#set:
|DocReference=INT  ISPE - GPP  Revision 3 (2015)
|DocValidityArea=INT
|DocScopes=INS
|DocName=ISPE - GPP
|DocVersion=Revision 3 (2015)
|DocStatus=Current
|DocType=International guideline
|DocLanguage=EN
|DocDescription=Guidelines for Good Pharmacoepidemiology Practices (GPP)
International Society for Pharmacoepidemiology (ISPE)
|DocRestricted=No
|DocSubmittedBy=Florian Adragna
|DocContributors=
}}</noinclude>

{{DocumentBox
|reference=INT  ISPE - GPP  Revision 3 (2015)
|validity_area=INT
|scopes=INS
|doc_name=ISPE - GPP
|version=Revision 3 (2015)
|status=Current
|doc_type=International guideline
|language=EN
|description=Guidelines for Good Pharmacoepidemiology Practices (GPP)
International Society for Pharmacoepidemiology (ISPE)
|official_link=https://www.pharmacoepi.org/resources/policies/guidelines-08027/
|restricted=No
|submitted_by=Florian Adragna
|contributors=
}}

<noinclude>
== References ==
{| class="wikitable" style="width:100%;"
! Reference !! Scope !! Document part !! Language !! Preview
|-
| [[Reference:INT ISPE - GPP Revision 3 (2015) -]] || INS || - || EN || Guidelines for Good Pharmacoepidemiology Practices (GPP) International Society for Pharmacoepidemiology (ISPE) https://www.pharmacoepi.org/resources/policies/guidelines-08027/
|-
| [[Reference:INT ISPE - GPP Revision 3 (2015) II.]] || INS || II. || EN || II. Protocol Development [...]
|}
</noinclude>